MENLO PARK, Calif., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio ® RS High Resolution Genetic Analyzer, today announced it has expanded the capabilities of its system through a major software upgrade, providing customers more tools for performing DNA base modification analysis and de novo genome assembly. Scientists from New England BioLabs (NEB) and Pacific Biosciences demonstrated the power of the new software in a paper this month titled " The Methylomes of Six Bacteria" in Nucleic Acids Research.
Pacific Biosciences Releases Software Upgrade To Advance Bacterial DNA Methylation Analysis And De Novo Genome Assembly Projects
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.